Prestige Consumer Healthcare Inc. (NYSE:PBH) Given Average Rating of "Moderate Buy" by Brokerages

Key Points

• The consensus rating for Prestige Consumer Healthcare Inc. (NYSE: PBH) is a "Moderate Buy", with three analysts recommending a hold and three a buy.
• The company's recent earnings report showed an EPS of $0.95, missing analysts' expectations, with revenue down 6.6% year-over-year.
• Institutional ownership is high, with 99.95% of shares held by institutional investors, indicating strong institutional interest in the stock.

Prestige Consumer Healthcare Inc. (NYSE:PBH - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six ratings firms that are presently covering the company, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $93.3333.

A number of research analysts have recently issued reports on the stock. Wall Street Zen downgraded shares of Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday, August 9th. Royal Bank Of Canada raised shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Finally, Canaccord Genuity Group cut their price target on shares of Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating for the company in a report on Friday, August 8th.

Prestige Consumer Healthcare Price Performance

PBH stock traded up $0.1450 during trading on Friday, hitting $65.0150. 345,392 shares of the company's stock traded hands, compared to its average volume of 387,991. The business has a fifty day simple moving average of $76.85 and a 200 day simple moving average of $81.54. The stock has a market capitalization of $3.20 billion, a price-to-earnings ratio of 15.26, a P/E/G ratio of 2.05 and a beta of 0.43. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.99 and a current ratio of 4.38. Prestige Consumer Healthcare has a 52 week low of $62.95 and a 52 week high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported $0.95 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.01 by ($0.06). The firm had revenue of $249.53 million during the quarter, compared to the consensus estimate of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.Prestige Consumer Healthcare's revenue was down 6.6% compared to the same quarter last year. During the same quarter last year, the business posted $0.90 EPS. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. As a group, research analysts expect that Prestige Consumer Healthcare will post 4.5 EPS for the current fiscal year.

Institutional Investors Weigh In On Prestige Consumer Healthcare

A number of large investors have recently modified their holdings of the business. Kayne Anderson Rudnick Investment Management LLC grew its holdings in shares of Prestige Consumer Healthcare by 45.3% during the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 1,580,819 shares of the company's stock worth $135,903,000 after buying an additional 493,199 shares in the last quarter. Geode Capital Management LLC lifted its position in shares of Prestige Consumer Healthcare by 0.7% during the second quarter. Geode Capital Management LLC now owns 1,413,041 shares of the company's stock worth $112,843,000 after purchasing an additional 9,455 shares in the last quarter. Invesco Ltd. lifted its position in shares of Prestige Consumer Healthcare by 24.7% during the first quarter. Invesco Ltd. now owns 1,321,800 shares of the company's stock worth $113,635,000 after purchasing an additional 261,537 shares in the last quarter. Congress Asset Management Co. lifted its position in shares of Prestige Consumer Healthcare by 1.8% during the second quarter. Congress Asset Management Co. now owns 1,009,595 shares of the company's stock worth $80,616,000 after purchasing an additional 18,015 shares in the last quarter. Finally, Westwood Holdings Group Inc. raised its holdings in Prestige Consumer Healthcare by 2.4% in the second quarter. Westwood Holdings Group Inc. now owns 881,908 shares of the company's stock valued at $70,420,000 after acquiring an additional 20,626 shares in the last quarter. Hedge funds and other institutional investors own 99.95% of the company's stock.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.